Skip over main navigation
  • Log in
  • Basket: (0 items)
Emerge Australia
  • Twitter
  • Facebook
  • Email
Donate Become a member
Menu
  • About us
    • What we do
    • Our team
    • Our Ambassador
    • Our impact
    • Annual reports
    • Position Statements
    • Contact us
  • ME/CFS information
    • ME/CFS Information
    • Long COVID
    • Post-Exertional Malaise
    • Management
    • For health professionals
    • For carers
    • Member stories
  • Research
    • ME/CFS biobank and registry
    • Research Digest
    • Health and Wellbeing Survey
    • Long COVID Registry
  • How to get help
    • Patient Support and Information Services
    • Telehealth Nurse Service
    • Online Community
    • GP Education Program
    • Accessing financial support
      • About NDIS
      • About DSP
      • NDIS and DSP Application Resources
      • Debt Helplines
  • Get involved
    • Give monthly
    • Donate
    • Fundraisers
    • Gift In Will
    • Emerge Australia Membership
    • Volunteer with us
    • Patient Advisory Group
    • Campaigns and advocacy resources
    • ME/CFS Awareness Week
  • Forum
  • News
  • Admin
    • Log in
  • Basket: (0 items)

Our impact

2020 Impact

July – December 2020 

In the second half of 2020, Emerge Australia has continued to make crucial in-roads in support of Australians living with ME/CFS.

Important highlights over this period include the launch of Open Medicine Foundation Australia (OMF Australia) as well as welcoming Casey Stoner as our official Ambassador.  

OMF Australia was founded by Emerge Australia in partnership with Open Medicine Foundation, enabling Australia to join the largest concerted worldwide non-profit effort to diagnose, treat and find a cure for ME/CFS. The Australian ME/CFS Centre for Collaborative Research will officially open early in 2021, led by Dr Chris Armstrong. The Centre, which joins existing research centres at Harvard, Stanford, Montreal, and Uppsala Universities seeks to develop a disease management and treatment approach that focuses on the individual patient and the biology that underlies their disease. This partnership also enables Emerge Australia to join the effort to fundraise for research here in Australia.  

It was wonderful to have the support of our newest Ambassador, Casey Stoner to launch the Australia ME/CFS Centre for Collaborative Research. Having the support of a well-known and much-loved Australian such as Casey, who is a two-time Moto GP World Champion and motorcycle racing legend, enabled the message to reach in excess of 100,000+ people via social media and over 230,000+ people on national news outlets. We look forward to continuing our work with Casey into 2021, as his support enables Emerge Australia to amplify our reach and reduce the stigma experienced by many living with ME/CFS.

Other highlights over this period include:

  • InfoLine: 95% of calls and 90% of emails are responded to within 24 hours
  • Telehealth Nurse Service: 480 outgoing client calls completed by the nurses
  • Education: Our GP education module delivered in partnership with ThinkGP celebrated one-year achieving in excess of 500-lifetime completions. Module 2 is under development and due to launch in early 2021!
  • Research: the first application for access to the Biobank has been approved.
  • Reach: 98,856 pages viewed on the website  

While the year commenced with the challenge of COVID-19 to Australia and the world, the year ended on a much more hopeful note, as life began to stabilise in a covid-normal world. With the launch of our new strategic plan, Emerge Australia is prepared for another productive year in 2021.

January – June 2020 

Emerge Australia is pleased to share our first bi-annual impact report, which demonstrates the important work achieved in support of Australians living with ME/CFS. 

Our most notable highlights from the first six months of activity in 2020 include: 

  • InfoLine – 95% of calls to the InfoLine were responded to in 24 hours, with an average of 233 emails sent each month 
  • Telehealth Nurse Service – 196 appointment requests were received with 362 outgoing client calls completed   
  • Campaigns – our #MillionsMissing campaign went global, reaching over 100,000 individuals across 12 countries 
  • Research – The ANCHOR Project into epidemiology and health economics of ME/CFS transcribed 55,000 words from patient focus groups for analyses 
  • Reach – 105,942 pages were viewed on the Emerge Australia website 

In addition, Emerge Australia responded to the needs of the community in light of the COVID-19 worldwide pandemic, producing 20 high-quality plain language information updates, which saw our web hits surge by 600%. This response from the community demonstrates Emerge Australia’s important role as one of the most trusted information sources for the ME/CFS community.

While the first half of 2020 has been a challenging time, we are hopeful that access to services such as Telehealth for medical appointments will remain, as our patient community is often excluded from accessing much needed medical care. We are campaigning hard for this alongside other advocacy aims, and look forward to providing further updates on our progress in the next bi-annual impact report, due in February 2021. 

View the Bi-annual Impact report infographic (January-June 2020) 


2019 Impact

2019 was a huge year for advocacy at Emerge Australia. We can’t thank the ME/CFS community enough for getting behind so many campaigns and ensuring that your collective voice was heard.

Your actions enabled us to secure meetings with politicians across the political spectrum and have led to increased awareness of the challenges faced by people impacted by ME/CFS in Parliament.

View the 2019 Advocacy impact infographic 

Published: 4th March, 2020

Updated: 10th March, 2021

Author:

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • Wests Tigers Jersey Competition

    Win a signed 2022 Wests Tigers Jersey thanks to our friends at Wests Tigers! To go into the draw to win this great prize, donate today to our Christmas Telehealth Appeal, to help us support those with ME/CFS and Long COVID. A donation of as little as $25 helps someone in need.

  • Research Digest 22/12/22

    Research Digest 22/12/22

    Welcome to the 91st edition of the Research Digest.  In our final edition for the year, a study evaluating aspects of the current IOM criteria is presented, as well as national and international research findings concerning Long Covid.   The final edition also puts a spotlight on the disbelief that people living with invisible disabilities like ME/CFS and Long Covid endure, and highlights Anne Wilson’s call for the government to better recognise those living with invisible disabilities.

  • Long COVID Registry

    Long COVID Registry

    In 2023, the Australian ME/CFS Biobank and Registry will expand to collect vital data and biosamples from patients who are experiencing symptoms of long-COVID.

  • ABC Article: Support for people with invisible illnesses

    ABC Article: Support for people with invisible illnesses

    Calls for greater government support for patients living with invisible illnesses like ME/CFS and Long COVID

Most read

  • Contact Us

    Contact Us

    Emerge Australia provides an information line where you can find out about the latest news and information about ME/CFS.

  • What we do

    What we do

    Who we are and what we do

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.

  • Post-Exertional Malaise (PEM)

    Post-Exertional Malaise (PEM)

    The central feature of ME/CFS, and a common symptom of Long COVID, is post-exertional malaise (PEM). PEM is when symptoms get worse after physical or mental activity.

  • Volunteer with us

    Volunteer with us

    Join our small, friendly and enthusiastic team as a volunteer

  • How is functional impairment assessed?

  • What is ME/CFS?

    What is ME/CFS?

    Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, digestive, immune and cardiac systems. ME is classified as a neurological disorder by the World Health Organization.

  • Coronavirus and ME - Simplified facts

    Coronavirus and ME - Simplified facts

    Many people with ME/CFS and other vulnerable communities in Australia are concerned about the impacts of the spreading coronavirus disease COVID-19. This is an easy-read resource with the latest information and advice.

  • Annual reports

    Annual reports for Emerge Australia

  • Patient Advisory Group

    Patient Advisory Group

    The Patient Advisory Group provides Emerge Australia with ongoing advice about the needs of the community, as well as invaluable input into projects

Sign up to our newsletter

* indicates required


Specific mailing lists

Helpful links

  • Sitemap
  • Accessibility
  • Terms & Conditions
  • Privacy Policy

Connect with us

  • Twitter
  • Facebook
  • YouTube


Get in touch with us

Emerge Australia
Level 7, 276 Flinders Street
Melbourne VIC 3000
1800 865 321
03 9529 1344
Media enquiries: Ron Smith [email protected]
 

Emerge Australia is registered as a charity with the Australian Charities and Not-for-profits Commission (ACNC). We are authorised by the Australian Tax Office as a deductible gift recipient (DGR). 

ABN/DGR: 22 385 438 041

Donations of $2 or more are tax-deductible. 

Emerge Australia acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and pays respect to their Elders past and present.

© 2019 Emerge Australia. All rights reserved.

Manage Cookie Preferences